| ||||||||||||||
|
|
|||||||||||||


*Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands; and
UPR 9050 CNRS, ESBS Université Louis Pasteur, Parc dInnovation, Illkirch, Strasbourg, France
Address correspondence and reprint requests to Dr. Albert Dahan, Department of Anesthesiology, Leiden University Medical Center P5-Q, PO Box 9600, 2300 RC Leiden, The Netherlands. Address e-mail to a.dahan{at}lumc.nl
N-methyl-D-aspartate receptor antagonism probably accounts for most of ketamines anesthetic effects; its analgesic properties are mediated partly via N-methyl-D-aspartate and partly via opioid receptors. We assessed the involvement of the µ-opioid receptor in S(+) ketamine-induced respiratory depression and antinociception by performing dose-response curves in exon 2 µ-opioid receptor knockout mice (MOR-/-) and their wild-type littermates (WT). The ventilatory response to increases in inspired CO2 was measured with whole body plethysmography. Two antinociceptive assays were used: the tail-immersion test and the hotplate test. S(+) ketamine (0, 10, 100, and 200 mg/kg intraperitoneally) caused a dose-dependent respiratory depression in both genotypes, with greater depression observed in WT relative to MOR-/- mice. At 200 mg/kg, S(+) ketamine reduced the slope of the hypercapnic ventilatory response by 93% ± 15% and 49% ± 6% in WT and MOR-/- mice, respectively (P < 0.001). In both genotypes, S(+) ketamine produced a dose-dependent increase in latencies in the hotplate test, with latencies in MOR-/- mice smaller compared with those in WT animals (P < 0.05). In contrast to WT mice, MOR-/- mice displayed no ketamine-induced antinociception in the tail-immersion test. These results indicate that at supraspinal sites S(+) ketamine interacts with the µ-opioid system. This interaction contributes significantly to S(+) ketamine-induced respiratory depression and supraspinal antinociception.
IMPLICATIONS: The involvement of the µ-opioid receptor system in S(+) ketamine-induced respiratory depression and spinal and supraspinal analgesia was demonstrated by performing experiments in mice lacking the µ-opioid receptor and in mice with intact µ-opioid receptors.
This article has been cited by other articles:
![]() |
Y. Sato, T. Onaka, E. Kobayashi, and N. Seo The Differential Effect of Cyclosporine on Hypnotic Response and Pain Reaction in Mice Anesth. Analg., November 1, 2007; 105(5): 1489 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Kaye, A. Baluch, J. Phelps, S. R. Baber, I. N. Ibrahim, J. M. Hoover, C. Zhang, and A. Fields An Analysis of Remifentanil in the Pulmonary Vascular Bed of the Cat Anesth. Analg., January 1, 2006; 102(1): 118 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okamoto, K. Minami, Y. Uezono, J. Ogata, M. Shiraishi, A. Shigematsu, and Y. Ueta The Inhibitory Effects of Ketamine and Pentobarbital on Substance P Receptors Expressed in Xenopus Oocytes Anesth. Analg., July 1, 2003; 97(1): 104 - 110. [Abstract] [Full Text] [PDF] |
||||
|